NASDAQ:BRKS - Brooks Automation Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $62.88
  • Forecasted Upside: -12.67 %
  • Number of Analysts: 8
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$72.00
▲ +0.43 (0.60%)
1 month | 3 months | 12 months
Get New Brooks Automation Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BRKS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BRKS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$62.88
▼ -12.67% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Brooks Automation in the last 3 months. The average price target is $62.88, with a high forecast of $77.00 and a low forecast of $40.00. The average price target represents a -12.67% upside from the last price of $72.00.
Buy
The current consensus among 8 polled investment analysts is to buy stock in Brooks Automation. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/12/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/10/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/9/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/8/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/6/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/4/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/3/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/3/2020

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/11/2020Smith Barney CitigroupBoost Price Target$55.00 ➝ $65.00High
i
11/11/2020B. RileyBoost Price TargetBuy$65.00 ➝ $75.00High
i
11/11/2020Credit Suisse GroupBoost Price TargetNeutral$40.00 ➝ $58.00High
i
11/11/2020Needham & Company LLCBoost Price TargetBuy$72.00 ➝ $77.00High
i
Rating by Stephen Unger at Needham & Company LLC
11/11/2020StephensUpgradeEqual Weight ➝ Overweight$55.00 ➝ $65.00High
i
11/9/2020KeyCorpInitiated CoverageOverweight$71.00High
i
9/20/2020Stifel NicolausUpgradeHold ➝ Buy$52.00Low
i
Rating by Patrick Ho at Stifel Nicolaus
8/4/2020Needham & Company LLCUpgradeHold ➝ BuyMedium
i
Rating by Stephen Unger at Needham & Company LLC
7/31/2020Credit Suisse GroupReiterated RatingHold$40.00Low
i
7/31/2020B. RileyBoost Price Target$55.00 ➝ $65.00High
i
6/29/2020B. RileyBoost Price Target$50.00 ➝ $55.00Low
i
6/22/2020Stifel NicolausDowngradeBuy ➝ Hold$46.00Low
i
6/2/2020Needham & Company LLCInitiated CoverageHoldHigh
i
Rating by Stephen Unger at Needham & Company LLC
5/1/2020CitigroupBoost Price TargetNeutral$37.00 ➝ $40.00Medium
i
5/1/2020B. RileyBoost Price TargetBuy$40.00 ➝ $50.00Low
i
4/19/2020Needham & Company LLCInitiated CoverageHoldLow
i
4/13/2020B. RileyBoost Price TargetBuy$30.00 ➝ $40.00Low
i
4/9/2020Needham & Company LLCInitiated CoverageHoldHigh
i
3/27/2020Janney Montgomery ScottReiterated RatingBuyMedium
i
3/19/2020B. RileyLower Price TargetBuy$54.00 ➝ $30.00Medium
i
2/10/2020CitigroupLower Price TargetNeutral$50.00 ➝ $44.00High
i
9/23/2019CitigroupDowngradeBuy ➝ Neutral$44.00 ➝ $42.00Medium
i
9/18/2019B. RileySet Price TargetBuy$47.00Low
i
Rating by Craig Ellis at B. Riley
9/17/2019Stifel NicolausSet Price TargetBuy$43.00Low
i
Rating by Patrick Ho at Stifel Nicolaus
8/23/2019StephensReiterated RatingEqual Weight$35.00High
i
8/22/2019StephensInitiated CoverageEqual WeightHigh
i
8/2/2019B. RileyReiterated RatingBuy ➝ Buy$51.00 ➝ $47.00High
i
4/30/2019Stifel NicolausBoost Price TargetBuy ➝ Buy$40.00 ➝ $43.00High
i
11/21/2018CitigroupLower Price TargetBuy ➝ Buy$41.00 ➝ $33.00High
i
11/20/2018B. RileyLower Price TargetBuy ➝ Buy$45.00 ➝ $42.00High
i
11/20/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$32.00 ➝ $26.00High
i
9/25/2018CitigroupBoost Price TargetBuy ➝ Buy$38.00 ➝ $41.00High
i
9/4/2018B. RileyBoost Price TargetBuy ➝ Buy$40.00 ➝ $50.00Low
i
8/28/2018Janney Montgomery ScottReiterated RatingFair Value ➝ Buy$40.00 ➝ $56.00High
i
8/7/2018StephensReiterated RatingBuy$35.00Low
i
7/13/2018CitigroupBoost Price TargetBuy$31.00 ➝ $37.00Low
i
5/2/2018B. RileyBoost Price TargetBuy ➝ Buy$38.00 ➝ $40.00Medium
i
5/2/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$32.00 ➝ $28.00Medium
i
5/2/2018CitigroupLower Price TargetBuy ➝ Buy$35.00 ➝ $31.00High
i
2/2/2018StephensReiterated RatingBuy$36.00Low
i
Rating by Drew Jones at Stephens
2/2/2018B. RileyBoost Price TargetBuy ➝ Buy$34.00 ➝ $38.00High
i
1/23/2018Janney Montgomery ScottSet Price TargetBuy$35.00Medium
i
Rating by Paul Knight at Janney Montgomery Scott
12/21/2017StephensInitiated CoverageOverweight$32.00Low
i
11/13/2017B. RileyReiterated RatingBuy$34.00N/A
i
11/10/2017CitigroupBoost Price TargetBuy$31.00 ➝ $34.00N/A
i
11/8/2017Stifel NicolausBoost Price TargetBuy$32.00 ➝ $38.00N/A
i
10/6/2017Needham & Company LLCReiterated RatingHoldN/A
i
9/18/2017Needham & Company LLCDowngradeBuy ➝ HoldHigh
i
9/14/2017Janney Montgomery ScottBoost Price TargetBuy$30.00 ➝ $35.00Low
i
8/8/2017B. RileyReiterated RatingBuy$34.00Low
i
8/6/2017Stifel NicolausUpgradeHold ➝ Buy$22.00 ➝ $32.00High
i
8/3/2017B. RileyReiterated RatingBuy$34.00High
i
8/3/2017Credit Suisse GroupReiterated RatingHold$26.00Medium
i
6/17/2017B. RileyReiterated RatingBuy$32.00Medium
i
6/12/2017B. RileyReiterated RatingBuy$32.00High
i
5/3/2017B. RileyReiterated RatingBuy$30.00Medium
i
4/28/2017B. RileyReiterated RatingBuy$30.00Low
i
4/28/2017Needham & Company LLCBoost Price TargetBuy ➝ Buy$22.00 ➝ $28.00Low
i
3/20/2017CitigroupBoost Price TargetBuy$26.00Low
i
2/7/2017B. RileyReiterated RatingBuy$22.00N/A
i
2/2/2017B. RileyReiterated RatingBuy$22.00N/A
i
2/2/2017Needham & Company LLCBoost Price TargetBuy$22.00N/A
i
1/16/2017B. RileyReiterated RatingBuy$21.00N/A
i
1/11/2017B. RileyReiterated RatingBuy$21.00N/A
i
1/9/2017Credit Suisse GroupUpgradeUnderperform ➝ Neutral$13.00 ➝ $17.00N/A
i
1/3/2017Stifel NicolausDowngradeBuy ➝ Hold$17.00N/A
i
11/30/2016Needham & Company LLCReiterated RatingBuy$17.00N/A
i
11/17/2016B. RileyReiterated RatingBuy$16.00N/A
i
11/12/2016B. RileyReiterated RatingBuy$16.00N/A
i
11/7/2016B. RileyReiterated RatingBuy$16.00N/A
i
10/12/2016CitigroupUpgradeNeutral ➝ Buy$12.50 ➝ $16.50N/A
i
9/13/2016Janney Montgomery ScottInitiated CoverageBuy$20.00N/A
i
9/12/2016CitigroupLower Price TargetNeutral$12.50 ➝ $9.30N/A
i
8/3/2016B. RileyReiterated RatingBuy$16.00N/A
i
Rating by Craig Ellis at B. Riley
7/29/2016B. RileyReiterated RatingBuy$16.00N/A
i
Rating by Craig Ellis at B. Riley
7/29/2016Needham & Company LLCBoost Price TargetBuy$13.00 ➝ $15.00N/A
i
6/7/2016B. RileyReiterated RatingBuy$16.50N/A
i
Rating by Craig Ellis at B. Riley
6/2/2016B. RileyReiterated RatingBuy$16.50N/A
i
Rating by Craig Ellis at B. Riley
5/4/2016B. RileyReiterated RatingBuy$16.50N/A
i
Rating by Craig Ellis at B. Riley
4/29/2016B. RileyReiterated RatingBuy$16.50N/A
i
Rating by Craig Ellis at B. Riley
4/29/2016Credit Suisse GroupReiterated RatingSell$9.80N/A
i
3/16/2016Credit Suisse GroupReiterated RatingUnderperform$10.00N/A
i
3/14/2016B. RileyReiterated RatingBuy$16.50N/A
i
Rating by Craig Ellis at B. Riley
3/9/2016B. RileyReiterated RatingBuy$16.50N/A
i
Rating by Craig Ellis at B. Riley
3/8/2016Credit Suisse GroupLower Price TargetUnderperform$10.00 ➝ $9.10N/A
i
3/4/2016B. RileyReiterated RatingBuy$16.50N/A
i
Rating by Craig Ellis at B. Riley
2/9/2016B. RileyReiterated RatingBuy$16.50N/A
i
Rating by Craig Ellis at B. Riley
2/4/2016B. RileyBoost Price TargetBuy$15.50 ➝ $16.50N/A
i
2/4/2016Credit Suisse GroupLower Price TargetUnderperform$10.00 ➝ $9.10N/A
i
(Data available from 12/3/2015 forward)
Brooks Automation logo
Brooks Automation, Inc. provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in three segments: Brooks Semiconductor Solutions Group, Brooks Life Sciences Services, and Brooks Life Sciences Products. The Brooks Semiconductor Solutions Group segment offers wafer automation and contamination controls solutions and services. Its products include atmospheric and vacuum robots, robotic modules, and tool automation systems that offer precision handling and clean wafer environments; and automated cleaning and inspection systems for wafer carriers, reticle pod cleaners, and stockers. It also offers repair and refurbishment, diagnostics, and installation services, as well as spare parts and productivity enhancement upgrade services. The Brooks Life Sciences Services segment provides gene sequencing and gene synthesis services, including next generation sequencing, sanger sequencing, gene synthesis, bioinformatics, and good laboratory practices regulatory services; on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery, and business continuity, as well as project management and consulting services; and sample intelligence software solutions and integration of customer technology. The Brooks Life Sciences Products segment offers automated cold storage systems; consumables, such as various formats of racks, tubes, caps, plates, and foils used for the storage and handling of samples in cold storage environments; and instruments used for labeling, bar coding, capping, de-capping, auditing, sealing, peeling, and piercing tubes and plates. The company serves semiconductor capital equipment and life sciences sample management markets in approximately 50 countries. Brooks Automation, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Read More

Today's Range

Now: $72.00
$71.98
$74.18

50 Day Range

MA: $59.23
$46.70
$73.41

52 Week Range

Now: $72.00
$21.19
$74.42

Volume

688,314 shs

Average Volume

513,181 shs

Market Capitalization

$5.32 billion

P/E Ratio

81.82

Dividend Yield

0.56%

Beta

2.01